Kowalski A, Stanley R O, Dennerstein L, Burrows G, Maguire K P
Br J Psychiatry. 1985 Oct;147:413-8. doi: 10.1192/bjp.147.4.413.
Clinical reports have suggested that antidepressant medication may contribute to the sexual dysfunction experienced by some depressed patients. A double-blind trial in a non-psychiatric male population compared amitriptyline (tricyclic), mianserin (tetracyclic) and placebo for their effects on nocturnal sexual arousal. In a three-way crossover design active drug or placebo were taken for two weeks preceding measurement of the frequency, amplitude and duration of nocturnal penile tumescence and synchronous sleep indices. Both active compounds significantly decreased the amplitude and the total duration of nocturnal erections. The effects on sleep indices were as previously reported. Few differences were found between the tricyclic and tetracyclic drugs. Some implications of these findings are considered.
临床报告表明,抗抑郁药物可能会导致一些抑郁症患者出现性功能障碍。在非精神科男性人群中进行的一项双盲试验,比较了阿米替林(三环类)、米安色林(四环类)和安慰剂对夜间性唤起的影响。采用三向交叉设计,在测量夜间阴茎勃起的频率、幅度和持续时间以及同步睡眠指标之前,让受试者服用活性药物或安慰剂两周。两种活性化合物均显著降低了夜间勃起的幅度和总持续时间。对睡眠指标的影响与先前报道的一致。三环类和四环类药物之间几乎没有差异。文中考虑了这些发现的一些影响。